Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Gcap14 Activators

Gcap14 Activators are a diverse class of chemical compounds that indirectly influence the activity of Gcap14 by modulating various signaling pathways and cellular processes. These activators work by either increasing the levels of second messengers like cAMP, which in turn activate kinases like PKA, or by inhibiting phosphatases that would otherwise dephosphorylate and deactivate proteins within signaling pathways. For instance, forskolin, by directly stimulating adenylate cyclase, raises cAMP levels, which leads to the activation of PKA-a kinase that may target Gcap14 or its associated regulatory proteins. On the other hand, compounds like okadaic acid and calyculin A inhibit protein phosphatases 1 and 2A, maintaining proteins in a phosphorylated state, which can influence the activity of Gcap14.

The specificity of these activators in regard to Gcap14 is not well-defined, as they act on broader cellular pathways that may impact a range of proteins. Nonetheless, the alterations in phosphorylation patterns and second messenger levels brought about by these compounds can potentially modulate the activity of Gcap14, albeit in an indirect manner. The functional mechanisms of these activators are diverse, ranging from alterations in kinase and phosphatase activity to shifts in cellular energy balance and second messenger dynamics. Each chemical's mode of action, whether it is through fostering or sustaining a phosphorylated state of proteins, or through modifying the concentrations of intracellular signaling molecules, presents a unique route through which Gcap14 activity could be modulated.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin directly stimulates adenylate cyclase, increasing cAMP levels. Elevated cAMP can activate PKA, which may phosphorylate Gcap14, altering its activity.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX inhibits phosphodiesterases, preventing cAMP degradation, thus potentially enhancing PKA activity and subsequent phosphorylation of Gcap14.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC) which could phosphorylate Gcap14 or related regulatory proteins, influencing Gcap14 activity.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium inhibits GSK-3, indirectly stabilizing proteins and potentially enhancing activity of Gcap14 through downstream signaling cascades.

Sodium Fluoride

7681-49-4sc-24988A
sc-24988
sc-24988B
5 g
100 g
500 g
$40.00
$46.00
$100.00
26
(4)

As a non-specific phosphorylation activator, sodium fluoride may activate kinases that phosphorylate Gcap14, modulating its function.

Okadaic Acid

78111-17-8sc-3513
sc-3513A
sc-3513B
25 µg
100 µg
1 mg
$291.00
$530.00
$1800.00
78
(4)

Okadaic acid inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation levels within the cell, potentially affecting Gcap14 activity.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$163.00
$800.00
59
(3)

Similar to okadaic acid, calyculin A specifically inhibits protein phosphatases 1 and 2A, which may result in increased phosphorylation and activation of Gcap14.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$65.00
$280.00
$400.00
48
(2)

AICAR activates AMPK, which can lead to phosphorylation of various proteins and might indirectly activate Gcap14 through altering cellular energy balance.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Isoproterenol is a beta-adrenergic agonist that elevates cAMP levels, potentially enhancing PKA activity and phosphorylation of Gcap14.

Chelerythrine

34316-15-9sc-507380
100 mg
$540.00
(0)

Chelerythrine is a PKC inhibitor that, by inhibiting PKC, may alter the phosphorylation status of Gcap14 through feedback loops or cross-talk with other kinases.